“Comparative clinical and laboratory evaluation of the effectiveness of a nanodispersed silica-based drug with antimicrobial properties for the local treatment of purulent inflammatory diseases of the maxillofacial area”, prmd, vol. 7, no. 1, pp. 25–31, Sep. 2024, doi: 10.31636/prmd.v7i1.4.